Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease

Pilar Rivero-Ríos, Patricia Gómez-Suaga, Belén Fernández, Jesús Madero-Pérez, Andrew J. Schwab, Allison D. Ebert, Sabine Hilfiker

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene comprise the most common cause of familial Parkinson's disease (PD), and variants increase the risk for sporadic PD. LRRK2 displays kinase and GTPase activity, and altered catalytic activity correlates with neurotoxicity, making LRRK2 a promising therapeutic target. Despite the importance of LRRK2 for disease pathogenesis, its normal cellular function, and the mechanism(s) by which pathogenic mutations cause neurodegeneration remain unclear. LRRK2 seems to regulate a variety of intracellular vesicular trafficking events to and from the late endosome in a manner dependent on various Rab proteins. At least some of those events are further regulated by LRRK2 in a manner dependent on two-pore channels (TPCs). TPCs are ionic channels localized to distinct endosomal structures and can cause localized calcium release from those acidic stores, with downstream effects on vesicular trafficking. Here, we review current knowledge about the link between LRRK2, TPC- and Rabmediated vesicular trafficking to and from the late endosome, highlighting a possible cross-talk between endolysosomal calcium stores and Rab proteins underlying pathomechanism(s) in LRRK2-related PD.

Original languageEnglish (US)
Pages (from-to)390-395
Number of pages6
JournalBiochemical Society transactions
StatePublished - Jun 1 2015
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Biochemistry


  • Autophagy
  • Endocytosis
  • Leucine-rich repeat kinase 2 (LRRK2)
  • Nicotinic acid adenine dinucleotide phosphate (NAADP)
  • Parkinson's disease
  • Rab protein


Dive into the research topics of 'Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease'. Together they form a unique fingerprint.

Cite this